Drug Profile
Aviptadil/phentolamine
Alternative Names: Invicorp; Phentolamine/aviptadil; PSD 510; VasopotinLatest Information Update: 20 Apr 2017
Price :
$50
*
At a glance
- Originator Senetek
- Developer Evolan Pharma; Plethora Solutions; Senetek
- Class Gastrointestinal hormones; Imidazoles; Neuropeptides; Peptide hormones; Vasodilators
- Mechanism of Action Alpha adrenergic receptor antagonists; Vasoactive intestinal peptide receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Erectile dysfunction
Most Recent Events
- 20 Apr 2017 Launched for Erectile dysfunction in Finland (Intracavernous) before April 2017 (Fimea website, April 2017)
- 20 Apr 2017 No recent reports on development identified - Preregistration for Erectile dysfunction in Germany (Intracavernous)
- 03 Apr 2015 Preregistration for Erectile dysfunction in United Kingdom, Germany, Sweden, Finland and Norway (Intracavernous) before April 2015